Fibromyalgia and Spasticity Flashcards
Duloxentine
• Indication
• MOA
• Elmination
• Adverse Effects
• Contraindications
Indication
• Fibromyalgia
MOA:
• Serotonin-Norepinephrine Reuptake inhibitor w/ greater inhibition of SEROTONIN reuptake
Note: there is NO direct action upon ANY receptors themselves OR upon reuptake of Dopamine
Elmination:
• Liver metabolizes (CYP 2D6 used), Urinary Elmination of byproducts
Adverse Effects:
• CV effects: increased HR and BP
• SIADH - resulting in hyponatremia
• BBW = SUICIDAL IDEATION
Contraindications:
• Do not give in severe liver dysfunction or chronic EtOHism.
• No not give to ppl. with CLOSED ANGLE glaucoma
• Ppl. taking MAOIs
Milnacipran
Indication
• Fibromyalgia
MOA:
• Serotonin-Norepinephrine Reuptake inhibitor w/ greater inhibition of *NOREPINEPHRINE* reuptake
Note_: there is NO direct action upon ANY receptors themselves OR upon reuptake of Dopamine_
Elmination:
• Liver metabolizes (NO CYPs used), Urinary Elmination of byproducts
Adverse Effects:
- *• CV effects**: increased HR and BP
- *• SIADH** - resulting in hyponatremia
- *• BBW** = SUICIDAL IDEATION
Contraindications:
• Do not give in severe liver dysfunction or chronic EtOHism.
• No not give to ppl. with CLOSED ANGLE glaucoma
• Ppl. taking MAOIs
Pregabalin
• Indication
• MOA
• Elmination
• Adverse Effects
• Contraindications
Indication:
• Fibromyalgia
MOA:
• Inhibition of the alpha-2-delta subunits of L-type Ca2+ channels leading to inhibition of the excitatory transmission by glutamate.
Elimination:
• Unchanged Renal Elmination - Reduce Dose in Renal Failure
Adverse Effects:
• Rebound on Withdrawl - Dependence Possible
• Additive Sedation with other CNS sedatives
• Suicidal thoughts/Depression
• Dizziness/Blurred Vision (especially the elderl y)
Contraindications:
• Reduce dose in renal failure and MONITOR SERUM CREATININE
Amitriptyline
• Indication
• Drug Class
Indication:
• Off-label use in fibromyalgia
Drug Class:
• Tricyclic Antidepressant
Cyclobenzprine
• Indication
• MOA
• Elmination
• Adverse Effects
• Contraindications
(aka Flexeril)
Indication:
• Fibromyalgia, Muscle Relaxer
MOA:
• Central Action (maybe at the brainstem)
Elmination:
• Enterohepatic Recirculation, EXTENSIVE hepatic metabolism (3A4, 1A2, 2D6). (old ppl. and EtOHics stay away)
Adverse Effects:
• Anticholinergic Action => Drowsiness, xerostomia, dizziness, fatigue, N/V/C, blurred vision
• Additive Effects with CNS depressants and EtOH
• Additive Effects with Anticholinergics
• PARALYTIC ILEUS (via anticholinergic effects) = MOST SIGNIFICANT EFFECT
• QT prolongation
Fluoxetine
• Indication
• MOA
Indication:
• Off-label use for fibromyalgia
MOA:
• Selective Serotonin Reuptake inhibitor
What are the only two differences between Duloxentine and Milnacipran?
Duloxentine:
• Metabolized by CYPs in the liver
• Greater Inhibition of Serotonin Reuptake than of NE reuptake
Milnacipran:
• Metabolized in the liver but NOT by CYPs
• Greater inhibition of NE uptake than Serotonin Reuptake
What are the 4 muscle relaxers we need to know for this block?
- **Carisoprodol
- Cyclobenzprine
- Methocarbamol
- Tizanidine**
Carisoprodol
• Indication
• MOA
• Elmination
• Adverse Effects
• Contraindications
Indication:
• Muscle Relaxer (fibromyalgia?)
MOA:
• CNS action in Reticular Activating System with NO DIRECT EFFECT on neuronal conduction, neuromuscular transmission, or muscle excitability. Relief is believed to be the result of Sedation.
Elimination:
• Extensive Hepatic CYP(2C19) Metabolism and Released in Urine - beware of anyone with hepatic or renal dysfunction that’s on this drug
Adverse Effects:
• Vertigo/Ataxia
• Temporary Vision loss
• Mydriasis/Orthostatic HTN
• Additive sedation when used with other sedatives
Contraindications:
• Watch out for Renal Dysfunction - MONITOR SERUM BUN/CREATININE
Methocarbamol
• Indication
• MOA
• Elmination
• Adverse Effects
• Contraindications
Indication:
• Muscle Relaxer - Muscle Spasm, Tetanus
MOA:
• Sedative action with altered pain perception, direct effects on muscle or excitation/contraction
Elmination:
• Hepatic Dealkylation and Hydroxylation with Urinary Elmination
Adverse Effects:
• Additive CNS depression
• Drowsiness, dizziness, lightheadedness, blurred vision, N/V
Contraindications:
• nothing too big just severe hepatic or renal dysfunction, but no risk big enough to warrant monitoring
Tizanidine
• Indication
• MOA
• Elmination
• Adverse Effects
• Contraindications
Indication:
• Muscle Relaxer - Multiple Sclerosis, Spasticity, Spinral Cord Trauma
MOA:
• Alpha-2 agonist on pre-synaptic receptor. Decreased activation in polysynaptic spinal cord motor neurons with reduction in muscle tone but not strength.
Elimination:
• Extensive First-Pass Metabolism
• Extensive Renal Excretion (watch out for the elderly)
Adverse Effects:
• Hepatotoxicity
• Hypotension with Reflex Tachycardiaand Reboud HTN on cessation (much less common than clonidine)
• Asthenia, Xerostomia, Dizziness, Sedation
Contradindications:
• People Need Regular LFTs
•Additive effects when given with other alpha-2 drugs (methyldopa, guanfacine, guanabenz)
Which of these drugs do you need to monitor Serum Creatinine and BUN for?
- Carisoprodol
- Pregabablin
What drugs are given for Spacticity? (4 of them)
- Baclofen
- Botulism Toxin
- Dantrolene
- Tizanidine
Balcofen
• Indication
• MOA
• Elmination
• Adverse Effects
• Contraindications
Indication:
• Muscle Spasticity (Multiple Sclerosis, Muscle Spasm, Spasticity, Spinal Cord Trauma)
MOA:
• GABAb agonist produces either: 1) inhibitory signals 2) hyperpolarizing signals
• Pain relief comes from inhibition of Substance P
Elimination:
• Orally active drug that undergoes extensive renal elimination - but no need for monitoring
Adverse Effects:
• BBW - AVOID ABRUPT discontinuance of therapy because of REBOUD NEURAL ACTIVITY => seizures, confusion, hallucinations, psychiatric disturbances, increased spasticity, RHABDOMYOLYSIS, death
- Hypotenstion with other antihypertensive agents and MAOIs
- Overall CNS Depression
Contraindications:
• Adjust dose of Anti-diabetic agents (blacofen may raise Blood Glucose)
Botulism Toxin
• Indication
• MOA
• Elmination
• Adverse Effects
• Contraindications